Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Using minoxidil for hair growth may cause skin lesions in some people, and taking breaks from nitrate patches for angina might worsen symptoms.

Testosterone, 4-hydroxyandrostenedione, and finasteride affect blood clotting differently in stressed heart conditions.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

GI197111X is best dissolved in Capmul MCM for trials.

The new minoxidil formulation could better promote hair growth for treating androgenic alopecia.

Agomelatine might help stop hair loss caused by valproate.

New drug uses show promise but need more research.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Plerixafor may help restore skin pigmentation safely.

The FDA rejected a testosterone drug again due to safety concerns.

Tadalafil and Finasteride may help treat aggressive melanoma.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

The minoxidil-finasteride combination is more effective for hair growth than minoxidil alone.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

The antidepressant escitalopram likely caused hair loss in a patient.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

The new treatment was safe and may effectively treat male pattern hair loss.

The treatment effectively reduces menopausal symptoms and is well tolerated.